An OAPol analysis published last month in Arthritis Care & Research examined the loss of quality-adjusted life years among racial minorities due to disparities in total knee replacement utilization. Click here for coverage by Reuters Health.
ECL: First, can you give us an overview of the TeMPO trial in your own words? Why are we conducting this study? What do we want to know? JS: TeMPO is a randomized controlled trial of treatments for degenerative meniscal tear among adults who also have mild-to-moderate knee osteoarthritis. All the treatments are non-operative, including strengthening exercises and physical therapy…